$NRDY

Nerdy Inc. (NRDY): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Nerdy Inc. (NRDY) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 20, 2026, John Paszterko, our Chief Operating Officer, was notified of the Company’s decision to end his service

Original reporting
Published Aug 21, 2026, 9:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 21, 2026, 9:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$NRDY
Neutral
medium confidence
Mentioned
$NRDY
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$NRDYNeutralLow
01

Why it matters

Provides the first public notice of the COO's exit, a material corporate action that may affect investor perception.

02

Market read

Executive turnover is a material corporate event; investors may adjust positions based on perceived leadership stability.

03

What to watch

No details on the reasons for termination or succession plan, which could hide deeper issues.

Relevance 6/10Novelty 5/10Timing: effective immediately

Background

The filing is a standard SEC 8‑K disclosure of an officer departure, required for material corporate events.

Company-level read

Ticker impact

$NRDYNeutralMedium confidence
Context

SEC Form 8‑K reports that Chief Operating Officer John Paszterko was terminated effective immediately on August 20, 2026.

Expected impact

Possible near‑term price dip as investors reassess leadership stability.

Evidence & confidence

Executive exits are material but without disclosed reasons or financial impact, the effect is uncertain.

Market effects

Minimal impact on the broader tech sector; leadership change is company‑specific.

No regional effect; the filing is U.S.‑focused.

Limited to investors tracking NRDY.

Counterpoint

The departure could be a strategic move to streamline operations, potentially improving long‑term performance.

Key entities

  • Nerdy Inc.

    Publicly listed U.S. company (ticker NRDY) reporting the executive departure.

  • John Paszterko

    Chief Operating Officer whose service was terminated.

Related articles

$NRDYMed

Major Virtual Tutoring Provider Shuts Down; Experts Cite Lack of Evidence

Nerdy, the parent of Varsity Tutors, said in a shareholder letter that Varsity Tutors for Schools will be wound down and services will be discontinued effective immediately, citing districts’ reduced federal relief spending and a focus on its parent- and college-focused tutoring model. Experts at Stanford and others said evidence of student gains was insufficient. A cited 2022 study reported i-Ready score gains of 9.82 vs 4.52 points.

$NRDYMedAI 8/10

Nerdy Q2 Earnings Call Highlights

Nerdy (NYSE:NRDY) reported Q2 gross margin of 64.7%, up 320 bps year over year. Net loss narrowed to $6.9 million, and non-GAAP adjusted EBITDA loss fell 68% to $0.9 million. Free cash flow was negative $6.3 million. The company plans to shut VT4S and exit First Tutors, cutting fixed costs by about $11 million and reducing 2026 revenue guidance to $168 million to $175 million.

$NRDYMed

Nerdy Inc. (NRDY): Results of Operations and Financial Condition

Nerdy Inc. (NRDY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Q2 I 2026 Shareholder Letter The Learning Experience Q2 2026 EARNINGS RELEASE 0 2 In this release 01 A Note to Our Shareholders 03 02 Second Quarter Financial Highlights 06 03 Second Quarter 2026 Key Results 07 04 Third Quarter and Full Year 2026 Outlook 08 05 Financ

$ASNDHigh

Ascendis Pharma (ASND) Authorizes $400M Share Buyback

Ascendis Pharma (ASND) authorized a $400M share buyback. Q2 2025 saw €315M product revenue, up 105% YoY, with €220M operating profit. Cash reserves grew to €812M. Buyback is discretionary, dependent on market conditions. YORVIPATH drove most revenue, while SKYTROFA and YUVIWEL contributed less. Costs increased due to expansion and R&D.